Epilepsy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient enrollment criteria: (1) Clinical manifestations and EEG results meet the 2017 ILAE epilepsy diagnostic criteria and epilepsy syndrome classification; (2) No other neurological or major diseases, and MRI routine sequence scan results are normal; (3) Good compliance and able to follow up on schedule. The study participant personally agrees and voluntarily signs the informed consent form after fully understanding the purpose and procedures of this study. 2. Healthy control enrollment criteria: (1) No other neurological or major diseases, and MRI routine sequence scan results are normal; (2) Good compliance and able to follow up on schedule. The study participant personally agrees and voluntarily signs the informed consent form after fully understanding the purpose and procedures of this study.
Exclusion criteria
Exclusion criteria: 1. Individuals with metal implants in the body: such as cochlear implants, pacemakers, etc., which may interfere with the test results; 2. History of other neurological or psychiatric disorders (e.g., brain trauma, schizophrenia); 3. Systemic diseases with significant clinical symptoms; 4. Unable to cooperate with MEG and MRI data acquisition; 5. Participants expected to be unable to comply with the informed consent form and complete the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brain structural parameters;Neural network parameter; | — |
Countries
China
Contacts
Nanjing Brain Hospital